In the News

1853 News Items found
Jason Lewis, PhD
During the June 8 edition of “MSK Science Spotlight,” radiochemist Jason Lewis, PhD, will share his perspectives on “Defying the Limitations of Antibodies for Imaging and Endoradiotherapy.”
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
The David H. Koch Center for Cancer Care has recently been recognized by a number of industry leaders for its innovative and resilient design, some of the many features that put the 750,000 square foot facility in a class of its own.
David Solit, MD
David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”
MSK radiation oncologist Beryl McCormick confers with a patient
In the Clinic
Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.
Ron Vale, PhD
June’s “MSK Science Spotlight” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute.
Dr.  Zsofia Stadler
During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.
MSK leadership on the stage in the Zuckerman Research Center auditorium.
Event
Memorial Sloan Kettering’s 41st annual ceremony recognized graduates and award winners with an online event.
Two doctors looking at a patient
Q&A
MSK radiation therapy experts set the record straight about the safety of this effective treatment.
Charles Rudin with lab member
During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).
Dr. Jun Mao with patient
During the upcoming ASCO Virtual Scientific Program, MSK Chief of Integrative Medicine, Jun J. Mao, MD, MSCE will be presenting a new study comparing the effectiveness of electro-acupuncture (EA) and auricular acupuncture (AA) versus usual care (UC) for chronic musculoskeletal pain in cancer survivors.